Table 1.
CaSR and modulations of digestive functions.
Cell types that express | Activating nutrient(s) | Role and function | Type of evidence | References |
---|---|---|---|---|
CELLS THAT REGULATE INGESTION AND DIGESTION | ||||
Tongue | ||||
Taste buds | , γ-glutamyl peptide | ↑bitter and kokumi taste perception | Pharmacological | Ohsu et al., 2010; Maruyama et al., 2012 |
Esophagus | ||||
Epithelial cells (basal cells) | Inflammation-modulating (?) | Biochemical | Justinich et al., 2008; Abdulnour-Nakhoul et al., 2015 | |
Stomach | ||||
G cells (ap & bl) | , Phe, spermine, Peptide, cinacalcet | ↑gastrin ![]() |
Pharmacogenetic | Ray et al., 1997; Buchan et al., 2001 |
D cells | Biochemical | Haid et al., 2012; Adriaenssens et al., 2015 | ||
Ghrelin cells (ap & bl) | Phe, Ala, peptide | ↑and ↓ghrelin secretion | Pharmacological | Engelstoft et al., 2013; Vancleef et al., 2015 |
Parietal cells (bl) | , Mg2+, amino acid | ↑gastric H+ secretion | Biochemical | Cheng et al., 1999; Caroppo et al., 2001; Geibel et al., 2001; Busque et al., 2005; Dufner et al., 2005 |
Mucous cells (ap & bl) | ↑mucous secretion | Biochemical | Rutten et al., 1999; Gilster et al., 2004 | |
Duodenum | ||||
I cells (ap & bl) | , Phe, Trp, peptide | ↑CCK![]() |
Pharmacogenetic | Sheinin et al., 2000; Hira et al., 2008; Nakajima et al., 2010, 2012; Liou et al., 2011; Wang et al., 2011 |
Pancreas | ||||
Acinar cells | ↑ secretion of pancreatic juice (?) | Biochemical | Bruce et al., 1999 | |
Ductal cells (ap) | ↑pancreatic fluid flow & solubility | Biochemical | Bruce et al., 1999 | |
α & β cells of Islet | , L-His | ↑insulin![]() |
Biochemical | Bruce et al., 1999; Squires et al., 2000; Komoto et al., 2003; Leech and Habener, 2003 |
Liver | ||||
Hepatocytes | , spermine | ↑bile flow | Biochemical | Canaff et al., 2001 |
Cholangiocytes (?) | ||||
CELLS THAT REGULATE ABSORPTION AND SECRETION | ||||
Small intestine | ||||
Villus cells (ap & bl) | ↑absorption | Biochemical | Chattopadhyay et al., 1998 | |
K cells | , amino acid | ↑GIP![]() |
Pharmacological | Mace et al., 2012 |
L cells | , amino acid, peptide | ↑GLP-1![]() |
Pharmacological | Leech and Habener, 2003; Mace et al., 2012; Diakogiannaki et al., 2013; Pais et al., 2016 |
Colon | ||||
Surface & crypt cells (ap & bl) | , polyamine, R568 | ↑absorption; ↓secretion | Pharmacogenetic | Chattopadhyay et al., 1998; Cheng et al., 2002; Cheng, 2012 |
↑barrier function; ↑gut immunity | Pharmacogenetic | Jouret et al., 2013; Macleod, 2013b; Cheng et al., 2014 | ||
↓proliferation; ↑differentiation | Pharmacogenetic | Chakrabarty et al., 2003; Rey O et al., 2012; Aggarwal et al., 2015 | ||
↓colon cancer | Pharmacogenetic | Kallay et al., 2000; Sheinin et al., 2000; Singh and Chakrabarty, 2013; Aggarwal et al., 2015; Singh et al., 2015 | ||
CELLS THAT REGULATE OTHER FUNCTIONS | ||||
Myofibroblasts | ↑wnt5a and BMP-2 secretion | Biochemical | Peiris et al., 2007; Pacheco and Macleod, 2008 | |
ENS | peptide, R568 | ↓secretion; ↓motility | Pharmacological | Chattopadhyay et al., 1998; Cheng, 2012; Muramatsu et al., 2014 |
Immune cells | ↓inflammation | Biochemical | Kelly et al., 2011 |
Ala, alanine; ap, apical membrane; bl, basolateral membrane; , extracellular calcium; CCK, cholecystokinin; ENS, enteric nervous system; GIP, glucose-dependent insulinotropic peptide; GLP-1, glucagon-like peptide-1; Phe, phenylalanine; PYY, peptide tyrosine tyrosine; Trp, tryptophan.